BioCentury
ARTICLE | Politics, Policy & Law

BMS to seek review of CAFC’s reversal of $1.2B judgment against Gilead

Bristol Myers says decision in Yescarta case does not affect its CAR T assets

August 26, 2021 11:18 PM UTC

BMS will challenge a ruling by a federal appeals court that has overturned a $1.2 billion judgement against Gilead. The U.S. Court of Appeals for the Federal Circuit ruled that a jury erred in when it ...



Access this Article